Prostate Cancer - Results from #24000

GU Cancers Symposium 2013 - Randomized phase II trial evaluating the optimal sequencing of sipuleucel-T and androgen deprivation therapy in patients with biochemically-recurrent prostate cancer, by Emmanuel S. Antonarakis, MD, et al. - Session Highlights February 23, 2013

Potentials and limitations of real-time elastography for prostate cancer detection: A whole-mount step section analysis - Abstract February 22, 2013

Long-term tumor control after brachytherapy for base-of-prostate cancer - Abstract February 22, 2013

Progressive transition from pre-planned to intraoperative optimizing seed implant: Post implementation analysis - Abstract February 22, 2013

The role of targeted focal therapy in the management of low-risk prostate cancer: Update on current challenges - Abstract February 22, 2013

Treatment of locally advanced prostate cancer: A case report and narrative review - Abstract February 22, 2013

The changing natural history of metastatic prostate cancer - Abstract February 22, 2013

Castrate-resistant prostate cancer: Postdocetaxel management - Abstract February 22, 2013

Dynamic PET/CT measurements of induced positron activity in a prostate cancer patient after 50-MV photon radiation therapy - Abstract February 22, 2013

GU Cancers Symposium 2013 - Serum IGF-1 levels are decreased in men with advanced prostate cancer treated with the ERα agonist, GTx-758, by Evan Y. Yu, MD, et al. - Poster February 22, 2013

Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer - Abstract February 22, 2013

Impact of bent distortion on accuracy of measurement during transrectal ultrasonography for prostatic imaging: A preliminary study - Abstract February 22, 2013

Risk of suicide in men with low-risk prostate cancer - Abstract February 22, 2013

Prostate cancer disease severity and country of origin among black men in the United States - Abstract February 22, 2013

GU Cancers Symposium 2013 - Variations in treatment modality use for the definitive management of prostate cancer in the United States, by Jay P. Ciezki, MD , et al. - Poster February 22, 2013

GU Cancers Symposium 2013 - Variations in treatment modality use for the definitive management of prostate cancer in the United States, by Jay P. Ciezki, MD , et al. - Session Highlights February 21, 2013

GU Cancers Symposium 2013 - Stereotactic body radiation (SBRT) following procedures for benign prostatic hyperplasia (BPH): A report of early toxicity, by Marie Kate Gurka, MD, et al. - Session Highlights February 21, 2013

GU Cancers Symposium 2013 - Exploratory analysis of the visceral disease patient subset in COU-AA-301, a phase 3 study of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC) - Session Highlights February 21, 2013

Racial disparities in survival after diagnosis of prostate cancer in Kentucky, 2001-2010 - Abstract February 21, 2013

Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer - Abstract February 21, 2013

Page 1201 of 1447